{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:25:07Z","timestamp":1740108307188,"version":"3.37.3"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,12,3]],"date-time":"2015-12-03T00:00:00Z","timestamp":1449100800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["491001"],"award-info":[{"award-number":["491001"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1010810"],"award-info":[{"award-number":["1010810"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s00228-015-1991-z","type":"journal-article","created":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T20:33:46Z","timestamp":1449088426000},"page":"377-378","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Concomitant administration of rifampicin and oxcarbazepine results in a significant decrease of the active MHD metabolite of oxcarbazepine"],"prefix":"10.1007","volume":"72","author":[{"given":"Ali","family":"Sigaroudi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerd A.","family":"Kullak-Ublick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Weiler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,12,3]]},"reference":[{"issue":"Suppl 5","key":"1991_CR1","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1111\/j.1528-1157.1994.tb05967.x","volume":"35","author":"M Schmutz","year":"1994","unstructured":"Schmutz M, Brugger F, Gentsch C, McLean MJ, Olpe HR (1994) Oxcarbazepine: preclinical anticonvulsant profile and putative mechanisms of action. Epilepsia 35(Suppl 5):S47\u2013S50","journal-title":"Epilepsia"},{"issue":"6","key":"1991_CR2","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/BF00609629","volume":"22","author":"M Theisohn","year":"1982","unstructured":"Theisohn M, Heimann G (1982) Disposition of the antiepileptic oxcarbazepine and its metabolites in healthy volunteers. Eur J Clin Pharmacol 22(6):545\u2013551","journal-title":"Eur J Clin Pharmacol"},{"issue":"8","key":"1991_CR3","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3109\/00498258609043567","volume":"16","author":"H Schutz","year":"1986","unstructured":"Schutz H, Feldmann KF, Faigle JW, Kriemler HP, Winkler T (1986) The metabolism of 14C-oxcarbazepine in man. Xenobiotica 16(8):769\u2013778","journal-title":"Xenobiotica"},{"issue":"2","key":"1991_CR4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF00280057","volume":"39","author":"PN Patsalos","year":"1990","unstructured":"Patsalos PN, Zakrzewska JM, Elyas AA (1990) Dose dependent enzyme induction by oxcarbazepine? Eur J Clin Pharmacol 39(2):187\u2013188","journal-title":"Eur J Clin Pharmacol"},{"issue":"Suppl. 6","key":"1991_CR5","first-page":"37","volume":"34","author":"WHJ Arnoldussen","year":"1993","unstructured":"Arnoldussen WHJ, Rentmeester T (1993) Interaction between oxcarbazepine and phenytoin. Epilepsia 34(Suppl. 6):37","journal-title":"Epilepsia"},{"issue":"12","key":"1991_CR6","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1111\/j.1499-1654.2000.001597.x","volume":"41","author":"G Barcs","year":"2000","unstructured":"Barcs G, Walker EB, Elger CE, Scaramelli A, Stefan H, Sturm Y, Moore A, Flesch G, Kramer L, D\u2019Souza J (2000) Oxcarbazepine placebo-controlled, dose-ranging trial in refractory partial epilepsy. Epilepsia 41(12):1597\u20131607","journal-title":"Epilepsia"},{"issue":"1","key":"1991_CR7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2125.1994.tb04234.x","volume":"37","author":"PJ McKee","year":"1994","unstructured":"McKee PJ, Blacklaw J, Forrest G, Gillham RA, Walker SM, Connelly D, Brodie MJ (1994) A double-blind, placebo-controlled interaction study between oxcarbazepine and carbamazepine, sodium valproate and phenytoin in epileptic patients. Br J Clin Pharmacol 37(1):27\u201332","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"1991_CR8","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1365-2125.1993.tb00378.x","volume":"36","author":"A Tartara","year":"1993","unstructured":"Tartara A, Galimberti CA, Manni R, Morini R, Limido G, Gatti G, Bartoli A, Strada G, Perucca E (1993) The pharmacokinetics of oxcarbazepine and its active metabolite 10-hydroxy-carbazepine in healthy subjects and in epileptic patients treated with phenobarbitone or valproic acid. Br J Clin Pharmacol 36(4):366\u2013368","journal-title":"Br J Clin Pharmacol"},{"issue":"9","key":"1991_CR9","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2165\/00003088-200342090-00003","volume":"42","author":"M Niemi","year":"2003","unstructured":"Niemi M, Backman JT, Fromm MF, Neuvonen PJ, Kivisto KT (2003) Pharmacokinetic interactions with rifampicin: clinical relevance. Clin Pharmacokinet 42(9):819\u2013850. doi: 10.2165\/00003088-200342090-00003","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"1991_CR10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/01.ftd.0000155342.93489.fd","volume":"27","author":"JA Armijo","year":"2005","unstructured":"Armijo JA, Vega-Gil N, Shushtarian M, Adin J, Herranz JL (2005) 10-Hydroxycarbazepine serum concentration-to-oxcarbazepine dose ratio: influence of age and concomitant antiepileptic drugs. Ther Drug Monit 27(2):199\u2013204","journal-title":"Ther Drug Monit"},{"key":"1991_CR11","author":"AN Jesus de","year":"2015","unstructured":"de Jesus AN, Wichert-Ana L, Coelho EB, Della Pasqua O, Alexandre Junior V, Takayanagui OM, Tozatto E, Marques MP, Lanchote VL (2015) Influence of verapamil on the pharmacokinetics of oxcarbazepine and of the enantiomers of its 10-hydroxy metabolite in healthy volunteers. Eur J Clin Pharmacol. doi: 10.1007\/s00228-015-1970-4","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"1991_CR12","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-0031-1286287","volume":"44","author":"C Hiemke","year":"2011","unstructured":"Hiemke C, Baumann P, Bergemann N, Conca A, Dietmaier O, Egberts K, Fric M, Gerlach M, Greiner C, Grunder G, Haen E, Havemann-Reinecke U, Jaquenoud Sirot E, Kirchherr H, Laux G, Lutz UC, Messer T, Muller MJ, Pfuhlmann B, Rambeck B, Riederer P, Schoppek B, Stingl J, Uhr M, Ulrich S, Waschgler R, Zernig G (2011) AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011. Pharmacopsychiatry 44(6):195\u2013235","journal-title":"Pharmacopsychiatry"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-015-1991-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-015-1991-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-015-1991-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T08:49:15Z","timestamp":1558687755000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-015-1991-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,3]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["1991"],"URL":"https:\/\/doi.org\/10.1007\/s00228-015-1991-z","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"type":"print","value":"0031-6970"},{"type":"electronic","value":"1432-1041"}],"subject":[],"published":{"date-parts":[[2015,12,3]]}}}